L_HRSVB
ID L_HRSVB Reviewed; 2166 AA.
AC O36635; O36637;
DT 03-MAR-2009, integrated into UniProtKB/Swiss-Prot.
DT 01-JAN-1998, sequence version 1.
DT 03-AUG-2022, entry version 103.
DE RecName: Full=RNA-directed RNA polymerase L;
DE Short=Protein L;
DE AltName: Full=Large structural protein;
DE AltName: Full=Replicase;
DE AltName: Full=Transcriptase;
DE Includes:
DE RecName: Full=RNA-directed RNA polymerase;
DE EC=2.7.7.48 {ECO:0000250|UniProtKB:P28887};
DE Includes:
DE RecName: Full=GTP phosphohydrolase {ECO:0000250|UniProtKB:P28887};
DE EC=3.6.1.- {ECO:0000250|UniProtKB:P28887};
DE Includes:
DE RecName: Full=GDP polyribonucleotidyltransferase {ECO:0000305};
DE EC=2.7.7.88 {ECO:0000250|UniProtKB:P28887};
DE AltName: Full=PRNTase {ECO:0000305};
DE Includes:
DE RecName: Full=mRNA cap methyltransferase {ECO:0000305};
DE EC=2.1.1.375 {ECO:0000250|UniProtKB:P03523};
DE AltName: Full=mRNA (guanine-N(7)-)-methyltransferase {ECO:0000250|UniProtKB:P03523};
DE Short=G-N7-MTase {ECO:0000250|UniProtKB:P03523};
DE AltName: Full=mRNA (nucleoside-2'-O-)-methyltransferase {ECO:0000250|UniProtKB:P03523};
DE Short=N1-2'-O-MTase {ECO:0000250|UniProtKB:P03523};
GN Name=L;
OS Human respiratory syncytial virus B (strain B1).
OC Viruses; Riboviria; Orthornavirae; Negarnaviricota; Haploviricotina;
OC Monjiviricetes; Mononegavirales; Pneumoviridae; Orthopneumovirus.
OX NCBI_TaxID=79692;
OH NCBI_TaxID=9606; Homo sapiens (Human).
RN [1]
RP NUCLEOTIDE SEQUENCE [GENOMIC RNA].
RX PubMed=9391135; DOI=10.1073/pnas.94.25.13961;
RA Karron R.A., Buonagurio D.A., Georgiu A.F., Whitehead S.S., Adamus J.E.,
RA Clements-Mann M.L., Harris D.O., Randolph V.B., Udem S.A., Murphy B.R.,
RA Sidhu M.S.;
RT "Respiratory syncytial virus (RSV) SH and G proteins are not essential for
RT viral replication in vitro: clinical evaluation and molecular
RT characterization of a cold-passaged, attenuated RSV subgroup B mutant.";
RL Proc. Natl. Acad. Sci. U.S.A. 94:13961-13966(1997).
CC -!- FUNCTION: Responsible for RNA synthesis (replicase and transcriptase),
CC cap addition, and cap methylation. Performs also the polyadenylation of
CC subgenomic mRNAs by a stuttering mechanism at a slipery stop site
CC present at the end of viral genes. The template is composed of the
CC viral RNA tightly encapsidated by the nucleoprotein (N). The viral
CC polymerase binds to the genomic RNA at two differents sites in the 3'
CC leader promoter thereby initiating either genome replication or mRNA
CC transcription. In the transcription mode, the polymerase performs the
CC sequential transcription of all mRNAs using a termination-reinitiation
CC mechanism responding to gene start and gene end signals. Some
CC polymerase disengage from the template at each gene junction, resulting
CC in a decreasing abundance of transcripts from the 3' to the 5' end of
CC the genome. The first gene is the most transcribed, and the last the
CC least transcribed. Needs as cofactors the phosphoprotein for
CC processivity and the M2-1 anti-termination protein. Polyribonucleotidyl
CC transferase (PRNTase) adds the cap structure when the nascent RNA chain
CC length has reached few nucleotides (By similarity). Ribose 2'-O
CC methylation of viral mRNA cap precedes and facilitates subsequent
CC guanine-N-7 methylation (By similarity). In the replication mode, the
CC polymerase replicates the whole viral genome without recognizing the
CC gene end transcriptional signals. The ability of the polymerase to
CC override the gene end signals as it is producing the antigenome is
CC probably due to replicative RNA becoming encapsidated with
CC nucleoprotein as it is synthesized (By similarity).
CC {ECO:0000250|UniProtKB:P03523, ECO:0000250|UniProtKB:P28887}.
CC -!- CATALYTIC ACTIVITY:
CC Reaction=a ribonucleoside 5'-triphosphate + RNA(n) = diphosphate +
CC RNA(n+1); Xref=Rhea:RHEA:21248, Rhea:RHEA-COMP:14527, Rhea:RHEA-
CC COMP:17342, ChEBI:CHEBI:33019, ChEBI:CHEBI:61557, ChEBI:CHEBI:140395;
CC EC=2.7.7.48; Evidence={ECO:0000255|PROSITE-ProRule:PRU00539};
CC -!- CATALYTIC ACTIVITY:
CC Reaction=GTP + H2O = GDP + H(+) + phosphate; Xref=Rhea:RHEA:19669,
CC ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:37565,
CC ChEBI:CHEBI:43474, ChEBI:CHEBI:58189;
CC Evidence={ECO:0000250|UniProtKB:P28887};
CC -!- CATALYTIC ACTIVITY:
CC Reaction=a 5'-end triphospho-adenylyl-adenylyl-cytidylyl-adenosine in
CC mRNA + GDP + H(+) = a 5'-end (5'-triphosphoguanosine)-adenylyl-
CC adenylyl-cytidylyl-adenosine in mRNA + diphosphate;
CC Xref=Rhea:RHEA:65436, Rhea:RHEA-COMP:16797, Rhea:RHEA-COMP:16799,
CC ChEBI:CHEBI:15378, ChEBI:CHEBI:33019, ChEBI:CHEBI:58189,
CC ChEBI:CHEBI:156484, ChEBI:CHEBI:156503; EC=2.7.7.88;
CC Evidence={ECO:0000250|UniProtKB:P28887};
CC -!- CATALYTIC ACTIVITY:
CC Reaction=a 5'-end (5'-triphosphoguanosine)-adenylyl-adenylyl-cytidylyl-
CC adenosine in mRNA + 2 S-adenosyl-L-methionine = a 5'-end (N(7)-methyl
CC 5'-triphosphoguanosine)-(2'-O-methyladenylyl)-adenylyl-cytidylyl-
CC adenosine in mRNA + H(+) + 2 S-adenosyl-L-homocysteine;
CC Xref=Rhea:RHEA:65376, Rhea:RHEA-COMP:16797, Rhea:RHEA-COMP:16798,
CC ChEBI:CHEBI:15378, ChEBI:CHEBI:57856, ChEBI:CHEBI:59789,
CC ChEBI:CHEBI:156483, ChEBI:CHEBI:156484; EC=2.1.1.375;
CC Evidence={ECO:0000250|UniProtKB:P03523};
CC -!- CATALYTIC ACTIVITY:
CC Reaction=a 5'-end (5'-triphosphoguanosine)-adenylyl-adenylyl-cytidylyl-
CC adenosine in mRNA + S-adenosyl-L-methionine = a 5'-end (5'-
CC triphosphoguanosine)-(2'-O-methyladenylyl)-adenylyl-cytidylyl-
CC adenosine in mRNA + H(+) + S-adenosyl-L-homocysteine;
CC Xref=Rhea:RHEA:65380, Rhea:RHEA-COMP:16797, Rhea:RHEA-COMP:16801,
CC ChEBI:CHEBI:15378, ChEBI:CHEBI:57856, ChEBI:CHEBI:59789,
CC ChEBI:CHEBI:156482, ChEBI:CHEBI:156484;
CC Evidence={ECO:0000250|UniProtKB:P03523};
CC -!- CATALYTIC ACTIVITY:
CC Reaction=a 5'-end (5'-triphosphoguanosine)-(2'-O-methyladenylyl)-
CC adenylyl-cytidylyl-adenosine in mRNA + S-adenosyl-L-methionine = a
CC 5'-end (N(7)-methyl 5'-triphosphoguanosine)-(2'-O-methyladenylyl)-
CC adenylyl-cytidylyl-adenosine in mRNA + S-adenosyl-L-homocysteine;
CC Xref=Rhea:RHEA:65440, Rhea:RHEA-COMP:16798, Rhea:RHEA-COMP:16801,
CC ChEBI:CHEBI:57856, ChEBI:CHEBI:59789, ChEBI:CHEBI:156482,
CC ChEBI:CHEBI:156483; Evidence={ECO:0000250|UniProtKB:P03523};
CC -!- COFACTOR:
CC Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC Evidence={ECO:0000250|UniProtKB:P28887};
CC Note=For RNA-directed RNA polymerase activity. Mn(2+) can stimulate de
CC novo initiation but it is inefficient at supporting elongation of de
CC novo initiated RNA. {ECO:0000250|UniProtKB:P28887};
CC -!- SUBUNIT: Interacts with the phosphoprotein (via C-terminus); the
CC association of P and L forms the polymerase complex.
CC {ECO:0000250|UniProtKB:P28887}.
CC -!- SUBCELLULAR LOCATION: Virion {ECO:0000250|UniProtKB:P28887}. Host
CC cytoplasm {ECO:0000250|UniProtKB:P28887}. Note=Localizes in cytoplasmic
CC inclusion bodies. {ECO:0000250|UniProtKB:P28887}.
CC -!- DOMAIN: Contains an RNA-dependent RNA polymerase (RdRp) domain, a
CC polyribonucleotidyl transferase (PRNTase or capping) domain and a
CC methyltransferase (MTase) domain. {ECO:0000250|UniProtKB:P28887}.
CC -!- SIMILARITY: Belongs to the paramyxovirus L protein family.
CC {ECO:0000305}.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR EMBL; AF013254; AAB82439.1; -; Genomic_RNA.
DR EMBL; AF013255; AAB82445.1; -; Genomic_RNA.
DR RefSeq; NP_056866.1; NC_001781.1.
DR SMR; O36635; -.
DR PRIDE; O36635; -.
DR GeneID; 1489827; -.
DR KEGG; vg:1489827; -.
DR Proteomes; UP000002472; Genome.
DR Proteomes; UP000180717; Genome.
DR GO; GO:0030430; C:host cell cytoplasm; IEA:UniProtKB-SubCell.
DR GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR GO; GO:0003924; F:GTPase activity; IEA:RHEA.
DR GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR GO; GO:0004482; F:mRNA (guanine-N7-)-methyltransferase activity; IEA:InterPro.
DR GO; GO:0003968; F:RNA-directed 5'-3' RNA polymerase activity; IEA:UniProtKB-KW.
DR InterPro; IPR003006; Ig/MHC_CS.
DR InterPro; IPR039736; L_poly_C.
DR InterPro; IPR026890; Mononeg_mRNAcap.
DR InterPro; IPR014023; Mononeg_RNA_pol_cat.
DR InterPro; IPR025786; Mononega_L_MeTrfase.
DR Pfam; PF14318; Mononeg_mRNAcap; 1.
DR Pfam; PF00946; Mononeg_RNA_pol; 1.
DR TIGRFAMs; TIGR04198; paramyx_RNAcap; 1.
DR PROSITE; PS00290; IG_MHC; 1.
DR PROSITE; PS50526; RDRP_SSRNA_NEG_NONSEG; 1.
DR PROSITE; PS51590; SAM_MT_MNV_L; 1.
PE 3: Inferred from homology;
KW ATP-binding; Host cytoplasm; Hydrolase; Magnesium; Metal-binding;
KW Methyltransferase; mRNA capping; mRNA processing; Multifunctional enzyme;
KW Nucleotide-binding; Nucleotidyltransferase; Reference proteome;
KW RNA-directed RNA polymerase; S-adenosyl-L-methionine; Transferase;
KW Viral RNA replication; Virion.
FT CHAIN 1..2166
FT /note="RNA-directed RNA polymerase L"
FT /id="PRO_0000365786"
FT DOMAIN 693..877
FT /note="RdRp catalytic"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00539"
FT DOMAIN 1820..2008
FT /note="Mononegavirus-type SAM-dependent 2'-O-MTase"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00923"
FT REGION 968..1460
FT /note="GDP polyribonucleotidyltransferase"
FT /evidence="ECO:0000250|UniProtKB:P28887"
FT ACT_SITE 1338
FT /note="Nucleophile; for GDP polyribonucleotidyltransferase
FT activity"
FT /evidence="ECO:0000250|UniProtKB:P03523"
FT ACT_SITE 1831
FT /note="For mRNA (nucleoside-2'-O-)-methyltransferase
FT activity"
FT /evidence="ECO:0000250|UniProtKB:Q6WB93"
FT ACT_SITE 1936
FT /note="For mRNA (nucleoside-2'-O-)-methyltransferase
FT activity"
FT /evidence="ECO:0000250|UniProtKB:Q6WB93"
FT ACT_SITE 1973
FT /note="For mRNA (nucleoside-2'-O-)-methyltransferase
FT activity"
FT /evidence="ECO:0000250|UniProtKB:Q6WB93"
FT ACT_SITE 2004
FT /note="For mRNA (nucleoside-2'-O-)-methyltransferase
FT activity"
FT /evidence="ECO:0000250|UniProtKB:Q6WB93"
FT BINDING 700
FT /ligand="Mg(2+)"
FT /ligand_id="ChEBI:CHEBI:18420"
FT /ligand_note="catalytic; for RNA-directed RNA polymerase
FT activity"
FT /evidence="ECO:0000250|UniProtKB:P28887"
FT BINDING 811
FT /ligand="Mg(2+)"
FT /ligand_id="ChEBI:CHEBI:18420"
FT /ligand_note="catalytic; for RNA-directed RNA polymerase
FT activity"
FT /evidence="ECO:0000250|UniProtKB:P28887"
FT BINDING 1853..1857
FT /ligand="substrate"
FT /ligand_note="for mRNA (nucleoside-2'-O-)-methyltransferase
FT activity"
FT /evidence="ECO:0000250|UniProtKB:Q6WB93"
FT VARIANT 822
FT /note="R -> K"
FT VARIANT 1662
FT /note="N -> H"
FT VARIANT 1886
FT /note="L -> I"
FT VARIANT 2030
FT /note="F -> L"
SQ SEQUENCE 2166 AA; 249767 MW; B2D8925C7935EFFD CRC64;
MDPIINGNSA NVYLTDSYLK GVISFSECNA LGSYLFNGPY LKNDYTNLIS RQSPLLEHMN
LKKLTITQSL ISRYHKGELK LEEPTYFQSL LMTYKSMSSS EQIATTNLLK KIIRRAIEIS
DVKVYAILNK LGLKEKDRVK PNNNSGDENS VLTTIIKDDI LSAVESNQSY TNSDKNHSVN
QNITIKTTLL KKLMCSMQHP PSWLIHWFNL YTKLNNILTQ YRSNEVKSHG FILIDNQTLS
GFQFILNQYG CIVYHKGLKK ITTTTYNQFL TWKDISLSRL NVCLITWISN CLNTLNKSLG
LRCGFNNVVL SQLFLYGDCI LKLFHNEGFY IIKEVEGFIM SLILNITEED QFRKRFYNSM
LNNITDAAIK AQKNLLSRVC HTLLDKTVSD NIINGKWIIL LSKFLKLIKL AGDNNLNNLS
ELYFLFRIFG HPMVDERQAM DAVRINCNET KFYLLSSLST LRGAFIYRII KGFVNTYNRW
PTLRNAIVLP LRWLNYYKLN TYPSLLEITE NDLIILSGLR FYREFHLPKK VDLEMIINDK
AISPPKDLIW TSFPRNYMPS HIQNYIEHEK LKFSESDRSR RVLEYYLRDN KFNECDLYNC
VVNQSYLNNS NHVVSLTGKE RELSVGRMFA MQPGMFRQIQ ILAEKMIAEN ILQFFPESLT
RYGDLELQKI LELKAGISNK SNRYNDNYNN YISKCSIITD LSKFNQAFRY ETSCICSDVL
DELHGVQSLF SWLHLTIPLV TIICTYRHAP PFIKDHVVNL NEVDEQSGLY RYHMGGIEGW
CQKLWTIEAI SLLDLISLKG KFSITALING DNQSIDISKP VRLIEGQTHA QADYLLALNS
LKLLYKEYAG IGHKLKGTET YISRDMQFMS KTIQHNGVYY PASIKKVLRV GPWINTILDD
FKVSLESIGS LTQELEYRGE SLLCSLIFRN IWLYNQIALQ LRNHALCNNK LYLDILKVLK
HLKTFFNLDS IDMALSLYMN LPMLFGGGDP NLLYRSFYRR TPDFLTEAIV HSVFVLSYYT
GHDLQDKLQD LPDDRLNKFL TCVITFDKNP NAEFVTLMRD PQALGSERQA KITSEINRLA
VTEVLSIAPN KIFSKSAQHY TTTEIDLNDI MQNIEPTYPH GLRVVYESLP FYKAEKIVNL
ISGTKSITNI LEKTSAIDTT DINRATDMMR KNITLLIRIL PLDCNKDKRE LLSLENLSIT
ELSKYVRERS WSLSNIVGVT SPSIMFTMDI KYTTSTIASG IIIEKYNVNS LTRGERGPTK
PWVGSSTQEK KTMPVYNRQV LTKKQRDQID LLAKLDWVYA SIDNKDEFME ELSTGTLGLS
YEKAKKLFPQ YLSVNYLHRL TVSSRPCEFP ASIPAYRTTN YHFDTSPINH VLTEKYGDED
IDIVFQNCIS FGLSLMSVVE QFTNICPNRI ILIPKLNEIH LMKPPIFTGD VDIIKLKQVI
QKQHMFLPDK ISLTQYVELF LSNKALKSGS NINSNLILVH KMSDYFHNAY ILSTNLAGHW
ILIIQLMKDS KGIFEKDWGE GYITDHMFIN LNVFFNAYKT YLLCFHKGYG KAKLECDMNT
SDLLCVLELI DSSYWKSMSK VFLEQKVIKY IVNQDTSLHR IKGCHSFKLW FLKRLNNAKF
TVCPWVVNID YHPTHMKAIL SYIDLVRMGL INVDKLTIKN KNKFNDEFYT SNLFYISYNF
SDNTHLLTKQ IRIANSELED NYNKLYHPTP ETLENISLIP VKSNNSNKPK FCISGNTESI
MMSTFSNKMH IKSSTVTTRF NYSKQDLYNL FPNVVIDRII DHSGNTAKSN QLYITTSHQT
SLVRNSASLY CMLPWHHVNR FNFVFSSTGC KISIEYILKD LKIKDPSCIA FIGEGAGNLL
LRTVVELHPD IRYIYRSLKD CNDHSLPIEF LRLYNGHINI DYGENLTIPA TDATNNIHWS
YLHIKFAEPI SIFVCDAELP VTANWSKIII EWSKHVRKCK YCSSVNRCIL IAKYHAQDDI
DFKLDNITIL KTYVCLGSKL KGSEVYLVLT IGPANILPVF DVVQNAKLIF SRTKNFIMPK
KTDKESIDAN IKSLIPFLCY PITKKGIKTS LSKLKSVVNG DILSYSIAGR NEVFSNKLIN
HKHMNILKWL DHVLNFRSAE LNYNHLYMIE STYPYLSELL NSLTTNELKK LIKITGSVLY
NLPNEQ